ASX - By Stock
|
DEL |
Re:
Ann: Delorean Corporation Market Update - FY24 Guidance
|
|
Gussington
|
60 |
23K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
60
|
23K
|
3
|
|
ASX - By Stock
|
DEL |
Re:
Ann: Delorean Corporation Market Update - FY24 Guidance
|
|
Gussington
|
60 |
23K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
60
|
23K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: Delorean Corporation Market Update - FY24 Guidance
|
|
Gussington
|
60 |
23K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
60
|
23K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: Delorean Corporation Market Update - FY24 Guidance
|
|
Gussington
|
60 |
23K |
9 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
60
|
23K
|
9
|
|
ASX - By Stock
|
DEL |
Re:
Ann: Delorean Corporation Market Update - FY24 Guidance
|
|
Gussington
|
60 |
23K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
60
|
23K
|
3
|
|
ASX - By Stock
|
DEL |
Re:
Ann: March 2024 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
13 |
10K |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
13
|
10K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
Ann: March 2024 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
13 |
10K |
0 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
13
|
10K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
Ann: March 2024 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
13 |
10K |
0 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
13
|
10K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Symposium
|
|
Gussington
|
20 |
7.7K |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
20
|
7.7K
|
4
|
|
ASX - By Stock
|
DEL |
Re:
Ann: December 2023 Interim Financial Report
|
|
Gussington
|
13 |
11K |
1 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
13
|
11K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
Gussington
|
21 |
5.6K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
21
|
5.6K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: December 2023 Interim Financial Report
|
|
Gussington
|
13 |
11K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
13
|
11K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: December 2023 Interim Financial Report
|
|
Gussington
|
13 |
11K |
2 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
13
|
11K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: DEL Awarded $5m Queensland Govt. Grant for QLD1 Project
|
|
Gussington
|
12 |
5.1K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
12
|
5.1K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
Ann: DEL Awarded $5m Queensland Govt. Grant for QLD1 Project
|
|
Gussington
|
12 |
5.1K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
12
|
5.1K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Charts
|
|
Gussington
|
37 |
14K |
5 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
37
|
14K
|
5
|
|
ASX - By Stock
|
DEL |
Re:
Ann: December 2023 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
32 |
13K |
2 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
32
|
13K
|
2
|
|
ASX - By Stock
|
DEL |
Re:
Ann: December 2023 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
32 |
13K |
0 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
32
|
13K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
Ann: December 2023 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
32 |
13K |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
32
|
13K
|
4
|
|
ASX - By Stock
|
DEL |
Re:
News: DEL Delorean Corporation Says Expects To Return To Profitability In FY24
|
|
Gussington
|
19 |
10K |
0 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
19
|
10K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
News: DEL Delorean Corporation Says Expects To Return To Profitability In FY24
|
|
Gussington
|
19 |
10K |
0 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
19
|
10K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
News: DEL Delorean Corporation Says Expects To Return To Profitability In FY24
|
|
Gussington
|
19 |
10K |
1 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
19
|
10K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Gussington
|
200 |
59K |
0 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
200
|
59K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
Gussington
|
200 |
59K |
5 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
200
|
59K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Update on Equity Raising
|
|
Gussington
|
28 |
10K |
13 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
28
|
10K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
TAVR MARKET Superiority
|
|
Gussington
|
87 |
30K |
4 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
87
|
30K
|
4
|
|
ASX - By Stock
|
MGF |
Re:
MGFO - AFR Article - 12x options return
|
|
Gussington
|
13 |
8.5K |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
13
|
8.5K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
Gussington
|
74 |
25K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
74
|
25K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
Gussington
|
74 |
25K |
20 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
74
|
25K
|
20
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
Gussington
|
74 |
25K |
0 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
25K
|
0
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Offer Accepted
|
|
Gussington
|
45 |
14K |
0 |
26/10/23 |
26/10/23 |
ASX - By Stock
|
45
|
14K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
Ann: September 2023 Quarterly Activities and Cash Flow Report
|
|
Gussington
|
11 |
6.9K |
2 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
11
|
6.9K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Commencement of American Depository Receipt Program
|
|
Gussington
|
12 |
5.0K |
2 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
12
|
5.0K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR Maintains Exceptional Results in New Patient Cohort
|
|
Gussington
|
35 |
14K |
6 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
35
|
14K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Medtronic taking the battle to Edwards.
|
|
Gussington
|
37 |
10K |
3 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
37
|
10K
|
3
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: Change of Director's Interest Notice
|
|
Gussington
|
11 |
4.3K |
0 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
11
|
4.3K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Gussington
|
425 |
128K |
3 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
128K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Gussington
|
425 |
128K |
10 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
128K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
Gussington
|
377 |
145K |
32 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
145K
|
32
|
|
ASX - By Stock
|
RAC |
Re:
Ann: EMD AML MDS Trial Expands to Europe
|
|
Gussington
|
94 |
32K |
11 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
94
|
32K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
NO-Vote support statement - draft 3
|
|
Gussington
|
32 |
8.0K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
32
|
8.0K
|
0
|
|
ASX - By Stock
|
DEL |
Re:
Ann: DEL Awarded Yarra Valley Water's $45m Bioenergy Project
|
|
Gussington
|
28 |
9.8K |
4 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
28
|
9.8K
|
4
|
|
ASX - By Stock
|
PH2 |
Re:
Ann: Serowe CSG Project Resource Upgrade to 315.7 BCF 2C
|
|
Gussington
|
9 |
4.7K |
8 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
9
|
4.7K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Gussington
|
687 |
259K |
8 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
259K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Gussington
|
687 |
259K |
29 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
259K
|
29
|
|
ASX - By Stock
|
WEB |
Re:
Ann: Appendix 4D and Half year financial results
|
|
Gussington
|
45 |
23K |
1 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
45
|
23K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Announces SleepCheck, a Sleep Apnoea Screening App
|
|
Gussington
|
452 |
191K |
6 |
01/04/20 |
01/04/20 |
ASX - By Stock
|
452
|
191K
|
6
|
|